A research team led by Prof. Ben Ko Chi-bun, Associate Professor of the PolyU Department of Applied Biology and Chemical ...
Glovadalen, a novel D1 receptor positive allosteric modulator, is linked to improve OFF time in patients with Parkinson’s ...
Disease modifying mechanism of action: short treatment course results in significant and durable clinical response in psoriasis patients si-544 is the first highly potent and selective Kv1.3 blocker ...
It has long been known that bacterial pathogens are becoming increasingly resistant to antibiotics. However, common ...
Grisso, a microbial science company, today announced the launch of its clinically-validated, precision probiotic product line, entering a market increasingly defined by consumer skepticism and demand ...
MariTide is now progressing into phase 3 trials, with a focus on its long-term safety and efficacy. Amgen expects to apply ...
Merus N.V., an oncology-focused company, announced the publication of research on petosemtamab, a bispecific antibody targeting EGFR and LGR5, in the journal "Cancers." The study highlights the ...
Gut microbiota as a biomarker for the efficacy of pembrolizumab in patients with advanced urothelial carcinoma treated in a prospective multicenter study. NECTIN4 RNA expression and clinical outcomes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback